ixCell
Latest round
- Series B
Last raised
- Aug 2025
Total raised
- Undisclosed
Investors
- 5
About ixCell
Founded in 2013 and based in Shanghai, china, ixCell operates primarily in the field of cell therapy by developing innovative cell-based pharmaceuticals., Ltd. The company develop cell therapies, including mesenchymal stem cell therapies, induced pluripotent stem cell (iPSC) products, and immunotherapy solutions. These therapies are designed to address medical conditions such as knee osteoarthritis, stroke, pulmonary fibrosis, autoimmune diseases, and solid tumors. The company generates revenue through clinical-grade products and services tailored for the biotechnology and pharmaceutical sectors.
Who invested in ixCell
5 investors across 1 round
See all investors in ixCell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 4, 2025
Amount
Undisclosed
Investors
Questions about ixCell
Who invested in ixCell?
ixCell has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ixCell raised?
ixCell has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ixCell last raise money?
ixCell's most recent round on record is a Series B, in Aug 2025.
What does ixCell do?
Founded in 2013 and based in Shanghai, china, ixCell operates primarily in the field of cell therapy by developing innovative cell-based pharmaceuticals.
Where is ixCell headquartered?
ixCell is headquartered in Shanghai, China.
Which VCs invest in companies like ixCell?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at ixCell's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ixCell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.